- Home
- / Jinling Pharmaceutical
Jinling Pharmaceutical
Stock Price
¥6.8
2024-10-29
Market Capitalization
¥4 B
2024-10-29
Revenue
¥3.1 B
FY, 2025
Jinling Pharmaceutical Summary
Company Summary
- Overview
- Jinling Pharmaceutical is a company that manufactures pharmaceutical products. It offers Mailuoning injection for the treatment of thrombo-occlusive vasculitis, arteriosclerotic occlusive disease, venous thrombosis, etc. The company provides medical healthcare services.
- Type
- Public
- Status
- Active
- Founded
- 1998
- HQ
- CN | view all locations
- Website
- http://jlyy000919.com/
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Jinling Pharmaceutical Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥764.0M
- Gross profit (Q1, 2026)
- ¥160.7M
- Net income (Q1, 2026)
- ¥29.6M
- Cash (Q1, 2026)
- ¥1.3B
- EBIT (Q1, 2026)
- ¥30.1M
- Enterprise value
- $2.9B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026